Clinical Trial Update: Investigation of the Effect of Vitamin K3-lotion for the Treatment of Cetuximab Induced Folliculitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating a vitamin K3 lotion for treating cetuximab-induced folliculitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Folliculitis

Drugs mentioned

• Cetuximab (cetuximab)
• Vitamin K3-lotion (Vitamin K3 lotion)

Snippet

Sponsor: Per Pfeiffer | Conditions: Folliculitis | Phase 2 | Status: COMPLETED